Cosette Announces the Approval and Launch of First Generic Version of RECTIV
Palatin Completes Sale of Vyleesi® to Cosette Pharma for up to $171 Million
Cosette Pharmaceuticals Launches Metronidazole Vaginal Gel 0.75%, AB-rated to MetroGel-Vaginal® 0.75%
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc. (“Cosette”), in partnership with SeegPharm SA (Lugano, Switzerland), is proud to announce the launch of Dapsone 5% Gel (NDC # 0713-0886-18, 0713-0886-60), an important and affordable alternative for patients to treat acne.
Cosette Pharmaceuticals Launches Betaine Anhydrous Powder, AB-rated to Cystadane® (betaine anhydrous for oral solution)
Cosette Pharmaceuticals Announces the Approval and Launch of Metronidazole Gel USP, 1%
Cosette Pharmaceuticals Announces the launch of Griseofulvin Oral Suspension, 125 mg/5 mL.
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a New Jersey-based specialty pharmaceutical company, today announced the appointment of Kevin Hickey as Vice President, Brand Sales and Marketing, bolstering its executive leadership team.
Cosette Pharmaceuticals Appoints Kevin Hickey, Vice President, Brand Sales and Marketing to Accelerate Transformation